• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Does Combined Vitamin D and Calcium Supplementation Reduce Risk of Fracture?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Yao et al. (JAMA Network Open, 2019) assessed the risks of fracture associated with 25-hydroxyvitamin D (25[OH]D) alone or in combination with calcium

METHODS:

  • Systematic Review and Meta-Analysis (through December 2018)
  • Data sources
    • PubMed, EMBASE, Cochrane Library, and other RCT databases
  • Inclusion criteria
    • Observational studies: Minimum 200 fracture cases
    • RCTs: Minimum 500 participants and reporting at least 10 incident fractures | Must have compared vitamin D or vitamin D and calcium with control
  • Study design
    • Two researchers independently extracted data and assessed possible bias
    • Rate ratios (RRs) were estimated using fixed-effects meta-analysis
  • Primary outcome
    • Any fracture and hip fracture

RESULTS:

Meta-analysis of observational studies: 11 met inclusion criteria

  • Each increase of 10.0 ng/mL (ie, 25 nmol/L) in 25 (OH)D concentration was associated with
    • Any fracture: Adjusted RR of 0.93 (95% CI, 0.89 to 0.96)
    • Hip fracture: Adjusted RR of 0.80 (95% CI, 0.75 to 0.86)

Meta-analysis of RCTs of vitamin D supplementation alone: 11 met inclusion criteria

  • Total of 34,243 participants | 2843 fractures | 740 hip fractures
  • There was no reduction in risk of hip or any fracture with vitamin D supplementation alone
    • Any fracture: RR of 1.06 (95% CI, 0.98 to 1.14)
    • Hip fracture: RR of 1.14 (95% CI, 0.98 to 1.32)
    • Quality of data limited: Infrequent intermittent dosing | Low daily doses of vitamin D | Inadequate number of participants

Meta-analysis of RCTs of vitamin D and calcium supplementation: 6 met inclusion criteria

  • Total of 49,282 participants | 5449 fractures | 730 hip fractures
  • Combined supplementation with vitamin D (daily doses of 400 to 800 IU) and calcium (daily doses of 1000 to 1200 mg) led to a reduced risk of hip and any fracture
    • Any fracture: RR 0.94 (95% CI, 0.89 to 0.99)
    • Hip fracture: RR, 0.84 (95% CI, 0.72 to 0.97)

CONCLUSION:

  • Supplementation with standard doses of vitamin D alone did not reduce risk of fracture
  • 7 large RCTs  are currently ongoing using higher doses of vitamin D (mean daily dose 2094 IU)
    • Authors stress the importance of waiting for these results before drawing conclusion regarding use of vitamin D alone and fracture risk
  • However, in this current study, daily supplementation with vitamin D and calcium reduced risk of hip fracture by 16% and any fracture by 6%
  • Authors caution that there are potential risks associated with supplementation
    • Combined vitamin D plus calcium is associated with cardiovascular disease
    • Kidney stones can result from excess calcium intake

Learn More – Primary Sources:

Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Try it Free  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Is Physical Activity Associated with Lower Risk of Fractures in Older Women?
Does Vitamin D Supplementation Decrease Mortality Risk?
Results from the VITAL Trial: Does Vitamin D Reduce Cardiovascular and Cancer Risk in the General Population?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site